1.Patel, G et al. (2015) Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infection Control & Hospital Epidemiology 29, 1099–1106.
2.Tamma, PD et al. (2017) Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant enterobacteriaceae bacteremia. Clinical Infectious Diseases 64, 257–264.
3.Veeraraghavan, B et al. (2017) Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience. Pathogens and Global Health 111, 240–246.
4.Yong, D et al. (2009) Characterization of a New Metallo-β-Lactamase Gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrobial Agents and Chemotherapy 53, 5046–5054.
5.Poirel, L et al. (2011) Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 55, 5403–5407.
6.Khan, AU, Maryam, L and Zarrilli, R (2017) Structure, Genetics and Worldwide Spread of New Delhi Metallo-beta-lactamase (NDM): a threat to public health. BMC Microbiology 17, 101.
7.van Duin, D and Doi, Y (2017) The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 8, 460–469.
8.Carrara, E, Bragantini, D and Tacconelli, E (2018) Combination versus monotherapy for the treatment of infections due to carbapenem-resistant enterobacteriaceae. Current Opinion in Infectious Diseases 31, 594–599.
9.Kumar, M et al. (2015) Risk factor analysis in clinical isolates of ESBL and MBL (Including NDM-1) producing Escherichia coli and Klebsiella species in a tertiary care hospital. Journal of Clinical and Diagnostic Research: JCDR 9, Dc08–Dc13.
10.Nabarro, LEB et al. (2017) Clinical and bacterial risk factors for mortality in children with carbapenem-resistant Enterobacteriaceae bloodstream infections in India. Pediatric Infectious Disease Journal 36, e161–e166.
11.Wang, Q et al. (2016) Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections. European Journal of Clinical Microbiology & Infectious Diseases 35, 1679–1689.
12.de Jager, P et al. (2015) Nosocomial outbreak of New Delhi metallo-beta-lactamase-1-producing gram-negative Bacteria in South Africa: a case-control study. PLoS One 10, e0123337.
13.Kim, SY et al. (2014) Characteristics of community-onset NDM-1-producing Klebsiella pneumoniae isolates. Journal of Medical Microbiology 63, 86–89.
14.Nordmann, P et al. (2012) Emergence of an autochthonous and community-acquired NDM-1-producing Klebsiella pneumoniae in Europe. Clinical Infectious Diseases 54, 150–151.
15.Guerra, B, Fischer, J and Helmuth, R (2014) An emerging public health problem: acquired carbapenemase-producing microorganisms are present in food-producing animals, their environment, companion animals and wild birds. Veterinary Microbiology 171, 290–297.
16.Yigit, H et al. (2001) Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 45, 1151–1161.
17.Poirel, L et al. (2011) Multiplex PCR for the detection of acquired carbapenemase genes. Diagnostic Microbiology and Infectious Disease 70, 119–123.
18.Dallenne, C et al. (2010) Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 65, 490–495.
19.Ellington, MJ et al. (2007) Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. Journal of Antimicrobial Chemotherapy 59, 321–322.
20.Poirel, L et al. (2011) OXA-163, an OXA-48-related class D beta-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 55, 2546–2551.
21.Nordmann, P, Boulanger, AE and Poirel, L (2012) NDM-4 metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrobial Agents and Chemotherapy 56, 2184–2186.
22.Parameswaran, R et al. (2011) Intravascular catheter-related infections in an Indian tertiary care hospital. Journal of Infection in Developing Countries 5, 452–458.
23.Khan, ID et al. (2017) Device-Associated Healthcare-Associated Infections (DA-HAI) and the caveat of multiresistance in a multidisciplinary intensive care unit. Medical Journal Armed Forces of India 73, 222–231.
24.Maamar, E et al. (2016) High prevalence of gut microbiota colonization with broad-spectrum cephalosporin resistant Enterobacteriaceae in a Tunisian Intensive Care Unit. Frontiers in Microbiology 7, 1859.
25.Mittal, G et al. (2016) Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India. BMC Microbiology 16, 138.
26.Zmarlicka, MT, Nailor, MD and Nicolau, DP (2015) Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics. Infection and Drug Resistance 8, 297–309.
27.Wiskirchen, DE et al. (2014) In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 58, 1671–1677.